Sanofi (SNY) Current Assets (2009 - 2026)

Sanofi has disclosed Current Assets across 18 years of filings, most recently posting $35.3 billion for Q1 2026.

• Current Assets for Q1 2026 came in at $35.3 billion, down 23.73% year-over-year; the trailing twelve-month figure through Mar 2026 was $35.3 billion (down 23.73% YoY), and the FY2025 annual result was $36.0 billion, down 20.83% from the prior year.
• Current Assets came in at $35.3 billion for Q1 2026 at Sanofi, down from $36.0 billion in the prior quarter.
• In the past five years, Current Assets ranged from a high of $46.3 billion in Q1 2025 to a low of $30.3 billion in Q2 2022.
• The 5-year median for Current Assets is $35.3 billion (2026), against an average of $37.1 billion.
• Across the five-year window, Current Assets surged 37.91% in 2024 and declined 23.73% in 2026, its largest moves.
• Sanofi's Current Assets stood at $34.8 billion in 2022, then retreated by 5.18% to $33.0 billion in 2023, then jumped by 37.91% to $45.5 billion in 2024, then dropped by 20.83% to $36.0 billion in 2025, then declined by 1.98% to $35.3 billion in 2026.
• The last three Current Assets figures came in at $35.3 billion (Q1 2026), $36.0 billion (Q4 2025), and $39.8 billion (Q3 2025), per Business Quant data.